(Q48031335)

7 February 2018

title

Suppression of inflammatory responses by surfactin, a selective inhibitor of platelet cytosolic phospholipase A2. (English)

1 reference

7 February 2018

author name string

K Kim

1

1 reference

7 February 2018

S Y Jung

2

1 reference

7 February 2018

D K Lee

3

1 reference

7 February 2018

J K Jung

4

1 reference

7 February 2018

J K Park

5

1 reference

7 February 2018

D K Kim

6

1 reference

7 February 2018

C H Lee

7

1 reference

7 February 2018

language of work or name

English

0 references

publication date

1 April 1998

1 reference

7 February 2018

published in

Biochemical Pharmacology

1 reference

7 February 2018

volume

55

1 reference

7 February 2018

issue

7

1 reference

7 February 2018

page(s)

975-985

1 reference

7 February 2018

Platelet activating factor: a biologically active phosphoglyceride

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900613-8

Mammalian non-pancreatic phospholipases A2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900613-8

Detection in human platelets of phospholipase A2 activity which preferentially hydrolyzes an arachidonoyl residue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900613-8

Purification and some properties of a phospholipase A2 from bovine platelets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900613-8

Purification of a high-molecular-mass form of phospholipase A2 from rat kidney activated at physiological calcium concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900613-8

Purification of a 110-kilodalton cytosolic phospholipase A2 from the human monocytic cell line U937.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900613-8

Suppression of inflammatory responses to 12-O-tetradecanoyl-phorbol-13-acetate and carrageenin by YM-26734, a selective inhibitor of extracellular group II phospholipase A2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900613-8

Selective inhibition of group II phospholipase A2 by quercetin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900613-8

Thielocin B3, a novel antiinflammatory human group II phospholipase A2 specific inhibitor from ascomycetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900613-8

Slow- and tight-binding inhibitors of the 85-kDa human phospholipase A2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900613-8

Surfactin, a crystalline peptidelipid surfactant produced by Bacillus subtilis: isolation, characterization and its inhibition of fibrin clot formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900613-8

Wetting of fibrin plate and apparent promotion of fibrinolysis by surfactin, a new bacterial peptidelipid surfactant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900613-8

Molecular Biology of Antibiotic Production in Bacillus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900613-8

Purification of a 100 kDa phospholipase A2 from spleen, lung and kidney: antiserum raised to pig spleen phospholipase A2 recognizes a similar form in bovine lung, kidney and platelets, and immunoprecipitates phospholipase A2 activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900613-8

Characterization of a novel phospholipase A2 activity in human brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900613-8

Tachyphylaxis in 12-0-tetradecanoylphorbol acetate- and arachidonic acid-induced ear edema

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900613-8

The mouse ear inflammatory response to topical arachidonic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900613-8

Exacerbation of rat adjuvant arthritis by intradermal injection of purified mammalian 14-kDa group II phospholipase A2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900613-8

Release of prostaglandins E and F in an algogenic reaction and its inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900613-8

A novel arachidonic acid-selective cytosolic PLA2 contains a Ca(2+)-dependent translocation domain with homology to PKC and GAP

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900613-8

Halo enol lactone inhibitors of chymotrypsin: burst kinetics and enantioselectivity of inactivation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900613-8

Mechanism of inhibition of dihydrofolate reductases from bacterial and vertebrate sources by various classes of folate analogues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900613-8

Modulation by glycyrrhetinic acid derivatives of TPA-induced mouse ear oedema

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900613-8

cPLA2 is phosphorylated and activated by MAP kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900613-8

10.1016/S0006-2952(97)00613-8

7 January 2021

Identifiers

DOI

1 reference

7 February 2018

PubMed ID

9605421

1 reference

7 February 2018